{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:31:48Z","timestamp":1790195508610,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.clinre.2013.10.008","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T10:26:18Z","timestamp":1385029578000},"page":"256-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoantibodies in primary biliary cirrhosis: Antinuclear envelope autoantibodies"],"prefix":"10.1016","volume":"38","author":[{"given":"Yannick","family":"Chantran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ballot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Johanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2013.10.008_bib0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"AASLD practice guidelines: management of primary biliary cirrhosis","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.10.008_bib0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: Management of cholestatic liver diseases","volume":"51","author":"Beuers","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00918255","article-title":"Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis","volume":"5","author":"Ruffatti","year":"1985","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0020","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.1840080438","article-title":"Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis","volume":"8","author":"Lozano","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.10.008_bib0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1172\/JCI114696","article-title":"The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore","volume":"86","author":"Courvalin","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2013.10.008_bib0030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.172.3.961","article-title":"Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis","volume":"172","author":"Courvalin","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinre.2013.10.008_bib0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/gast.1996.v110.pm8608894","article-title":"Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis","volume":"110","author":"Wesierska-Gadek","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.10.008_bib0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00351173","article-title":"Primary biliary cirrhosis sera recognize not only gp210 but also proteins of p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope","volume":"23","author":"Miyachi","year":"1996","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.clinre.2013.10.008_bib0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2004.02432.x","article-title":"The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence","volume":"136","author":"Ou","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00033-7","article-title":"Profile and clinical significance of antinuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study","volume":"20","author":"Miyachi","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.10.008_bib0055","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1084\/jem.178.6.2237","article-title":"Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210","volume":"178","author":"Nickowitz","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinre.2013.10.008_bib0060","first-page":"495","article-title":"Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope","volume":"21","author":"Tartakovsky","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.10.008_bib0065","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.510230512","article-title":"Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis","volume":"23","author":"Bandin","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.10.008_bib0070","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3748\/wjg.v16.i39.4938","article-title":"Perinuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients","volume":"16","author":"Sfakianaki","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/sarh.2001.20266","article-title":"Antinuclear envelope antibodies: clinical associations","volume":"30","author":"Nesher","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.10.008_bib0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcla.20170","article-title":"Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis","volume":"21","author":"Bauer","year":"2007","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.clinre.2013.10.008_bib0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnosic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2013.10.008_bib0090","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1572-0241.2004.40416.x","article-title":"Serum immunological profile in patients with chronic autoimmune cholestasis","volume":"99","author":"Romero-G\u00f6mez","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1478-3231.2007.01651.x","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis","volume":"28","author":"Liu","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2013.10.008_bib0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.10.008_bib0105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-8278(98)80220-1","article-title":"Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation","volume":"28","author":"Dubel","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0160","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0168-8278(98)80233-X","article-title":"The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis","volume":"28","author":"Luettig","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1196\/annals.1398.058","article-title":"Characterization of autoantibodies against components of the nuclear pore complexes. High frequency of anti-p62 nucleoporin antibodies","volume":"1109","author":"Wesierska-Gadek","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinre.2013.10.008_bib0125","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.autrev.2012.03.005","article-title":"Primary biliary cirrhosis and the nuclear pore complex","volume":"11","author":"Duarte-Rey","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.10.008_bib0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaut.2005.10.007","article-title":"Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis","volume":"26","author":"Nakamura","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.10.008_bib0135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1872-034X.2010.00631.x","article-title":"Analysis of HLA-DRB1 polymorphisms in japanese patients with primary biliary cirrhosis (PBC): the HLA-DRB1 polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC","volume":"40","author":"Nakamura","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2013.10.008_bib0140","doi-asserted-by":"crossref","first-page":"487521","DOI":"10.1155\/2012\/487521","article-title":"TRAF1 gene polymorphism correlates with the titre of gp210 antibody in patients with primary biliary cirrhosis","volume":"2012","author":"Kempinska-podhorodecka","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2249.2012.04577.x","article-title":"Epitope-specific antinuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent","volume":"168","author":"Yang","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2013.10.008_bib0150","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0016-5085(03)00387-1","article-title":"Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis","volume":"124","author":"Shimoda","year":"2003","journal-title":"Gastroenterology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:19:43Z","timestamp":1761895183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740113002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S2210740113002271"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2013.10.008","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in primary biliary cirrhosis: Antinuclear envelope autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2013.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}